Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:...
-
Did Synopsys, Inc. Mislead Investors? Contact BFA Law by Tomorrow’s December 30 Legal Deadline if You Suffered Losses
-
Synopsys, Inc. IP Underperformance Leads to Securities Class Action – Contact BFA Law before Tuesday’s December 30 Legal Deadline
-
Synopsys, Inc. Investors May have been Affected by Fraud – Contact BFA Law by December 30 to Protect Your Rights
-
Synopsys, Inc. Stock Drops 36% after IP Underperformance Announced – Contact BFA Law by December 30 Securities Class Action Deadline
-
PHILADELPHIA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before December 30
-
Lose Money on Synopsys, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law by December 30 Deadline
-
SNPS STOCK NOTICE: Synopsys, Inc. Faces Securities Fraud Class Action after 36% Stock Drop – Investors with Losses Urged to Contact BFA Law